Autologous blood storage, intraoperative TXA administration, and simultaneous exposure should be considered to minimize perioperative allogeneic blood transfusion in ASD surgery, particularly in patients with anticipated lengthy surgeries.
Keyphrases
- red blood cell
- stem cell transplantation
- minimally invasive
- bone marrow
- coronary artery bypass
- cardiac surgery
- patients undergoing
- autism spectrum disorder
- surgical site infection
- spinal cord
- hematopoietic stem cell
- attention deficit hyperactivity disorder
- stem cells
- mesenchymal stem cells
- cell therapy
- percutaneous coronary intervention
- coronary artery disease
- intellectual disability